Previous studies have suggested that hypokalemia may be a marker of unopposed Ang II,33,34 and therefore, hypokalemia may modify the association between anti-hypertensive therapy and outcomes in COVID-19 infection. This evidence concerns the gene AGT and Hypokalemia.